U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
194101194101Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerActive, not recruitingNo Results AvailableAcute Undifferentiated Leukemia|Adult Nasal Type Extranodal NK/T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Childhood Burkitt Lymphoma|Childhood Diffuse Large Cell Lymphoma|Childhood Grade III Lymphomatoid GranulomatosRadiation: total-body irradiation|Drug: fludarabine phosphate|Drug: cyclosporine|Drug: mycophenolate mofetil|Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation|Biological: donor lymphocytes|Procedure: peripheral blood stem cell transplantation|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00006251
194102194102Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's LymphomaActive, not recruitingNo Results AvailableLymphomaDrug: chlorambucil|Drug: dexamethasone|Drug: fludarabine phosphate|Drug: mitoxantrone hydrochloridehttps://ClinicalTrials.gov/show/NCT00006250
194103194103Interferon Alfa Following Surgery in Treating Patients With Stage III MelanomaActive, not recruitingNo Results AvailableMelanoma (Skin)Biological: pegylated interferon alfa|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00006249
194104194104S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck CancerCompletedNo Results AvailableHead and Neck CancerDrug: cisplatin|Drug: fluorouracil|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00006248
194105194105SU5416 in Treating Children With Recurrent or Progressive Brain TumorsTerminatedNo Results AvailableBrain and Central Nervous System TumorsDrug: semaxanibhttps://ClinicalTrials.gov/show/NCT00006247
194106194106Busulfan in Treating Children and Adolescents With Refractory CNS CancerCompletedNo Results AvailableBrain and Central Nervous System Tumors|Childhood Germ Cell Tumor|Leukemia|Lymphoma|Metastatic Cancer|Retinoblastoma|SarcomaDrug: busulfanhttps://ClinicalTrials.gov/show/NCT00006246
194107194107Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous PaclitaxelCompletedNo Results AvailableEsophageal CancerDrug: alvocidib|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00006245
194108194108Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple MyelomaActive, not recruitingNo Results AvailableRefractory Multiple Myeloma|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple MyelomaDrug: melphalan|Biological: recombinant interferon alfa|Biological: aldesleukin|Procedure: in vitro-treated peripheral blood stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00006244
194109194109Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant MelanomaCompletedNo Results AvailableRecurrent Melanoma|Stage IV MelanomaBiological: tyrosinase peptide|Biological: MART-1:27-35 peptide vaccine|Biological: gp100 antigen|Biological: incomplete Freund's adjuvant|Biological: sargramostim|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00006243
194110194110BMS-214662 in Treating Patients With Advanced Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: BMS-214662|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00006242
194111194111Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's LymphomaCompletedNo Results AvailableLymphomaBiological: filgrastim|Drug: chemotherapy|Procedure: in vitro-treated peripheral blood stem cell transplantation|Procedure: peripheral blood stem cell transplantation|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00006241
194112194112Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid LeukemiaCompletedNo Results AvailableLeukemiaBiological: sargramostim|Drug: dexamethasone|Drug: oral sodium phenylbutyratehttps://ClinicalTrials.gov/show/NCT00006240
194113194113Phenylbutyrate and Tretinoin in Treating Patients With Hematologic CancerCompletedNo Results AvailableLeukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative DiseasesDrug: sodium phenylbutyrate|Drug: tretinoinhttps://ClinicalTrials.gov/show/NCT00006239
194114194114S0008: Chemotherapy Plus Biological Therapy in Treating Patients With MelanomaCompletedHas ResultsMelanoma (Skin)Biological: interleukin-2|Biological: filgrastim|Biological: interferon alfa|Drug: cisplatin|Drug: dacarbazine|Drug: vinblastinehttps://ClinicalTrials.gov/show/NCT00006237
194115194115Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNo Results AvailableFallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity CancerDrug: carboplatin|Drug: pegylated liposomal doxorubicin hydrochloridehttps://ClinicalTrials.gov/show/NCT00006235
194116194116Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the BoneCompletedNo Results AvailableMetastatic Cancer|SarcomaProcedure: peripheral blood stem cell transplantation|Radiation: holmium Ho 166 DOTMPhttps://ClinicalTrials.gov/show/NCT00006234
194117194117Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: therapeutic allogeneic lymphocytes|Drug: cyclosporine|Drug: fludarabine phosphate|Drug: mycophenolate mofetil|Procedure: peripheral blood stem cell transplantation|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00006233
194118194118Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple MyelomaCompletedNo Results AvailableMultiple Myeloma and Plasma Cell NeoplasmDrug: dexamethasone|Drug: doxorubicin hydrochloride|Drug: idarubicin|Drug: vincristine sulfatehttps://ClinicalTrials.gov/show/NCT00006232
194119194119Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant MesotheliomaCompletedNo Results AvailableMalignant Mesothelioma|Perioperative/Postoperative ComplicationsProcedure: quality-of-life assessment|Procedure: standard follow-up care|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00006231
194120194120Nitrocamptothecin in Treating Patients With Advanced Ovarian CancerCompletedNo Results AvailableOvarian CancerDrug: rubitecanhttps://ClinicalTrials.gov/show/NCT00006230
194121194121Paclitaxel and Carboplatin With or Without BMS-275291 in Treating Patients With Advanced or Metastatic Non-small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: carboplatin|Drug: paclitaxel|Drug: rebimastathttps://ClinicalTrials.gov/show/NCT00006229
194122194122Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast CancerCompletedNo Results AvailableHER2-positive Breast Cancer|Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast CancerBiological: trastuzumab|Biological: aldesleukin|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00006228
194123194123Paclitaxel in Treating Patients With Ovarian Stromal CancerActive, not recruitingNo Results AvailableOvarian Stromal CancerDrug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00006227
194124194124Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaCompletedNo Results AvailableB-cell Chronic Lymphocytic Leukemia|Refractory Chronic Lymphocytic LeukemiaDrug: thalidomide|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00006226
194125194125Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic CancerCompletedNo Results AvailableBreast Cancer|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic/Myeloproliferative DiseasesBiological: filgrastim|Biological: recombinant flt3 ligand|Biological: recombinant human thrombopoietin|Biological: recombinant interleukin-3|Procedure: in vitro-treated peripheral blood stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00006225
194126194126Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the CervixTerminatedNo Results AvailableCervical CancerDrug: gemcitabine hydrochloridehttps://ClinicalTrials.gov/show/NCT00006224
194127194127flt3L in Treating Patients With Acute Myeloid LeukemiaCompletedNo Results AvailableLeukemiaBiological: recombinant flt3 ligandhttps://ClinicalTrials.gov/show/NCT00006223
194128194128EMD 121974 in Treating Patients With HIV-Related Kaposi's SarcomaTerminatedNo Results AvailableSarcomaDrug: cilengitidehttps://ClinicalTrials.gov/show/NCT00006222
194129194129BMS-247550 in Treating Patients With Advanced CancersCompletedNo Results AvailableLymphoma|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol SpecificDrug: ixabepilonehttps://ClinicalTrials.gov/show/NCT00006221
194130194130Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous TherapyTerminatedNo Results AvailableLeukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic SyndromesDrug: arsenic trioxide|Drug: tretinoinhttps://ClinicalTrials.gov/show/NCT00006220

* Görseller ve İçerik tekif hakkına sahip olabilir